Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion

Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion

US Patent 7901685 · Granted Mar 8, 2011

Estimated economic value: $2,508,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for reducing viral load in HIV-1 infected patients2019
PSMA antibodies and uses thereof2017
Methods for inhibiting HIV-1 replication involving the administration of an anti2014
PSMA antibodies and uses thereof2013
Inhibition of HIV-1 replication by disruption of the processing of the viral cap2012
Compositions of PSMA antibodies2012
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV2011
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV2011
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV2011
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion2011
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion2011
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion2011